Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

177 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Enhancing adherence to antiretroviral therapy at the HIV clinic in resource constrained countries; the Tanzanian experience.
Mugusi F, Mugusi S, Bakari M, Hejdemann B, Josiah R, Janabi M, Aboud S, Aris E, Swai H, Mhalu F, Biberfeld G, Pallangyo K, Sandstrom E. Mugusi F, et al. Among authors: janabi m. Trop Med Int Health. 2009 Oct;14(10):1226-32. doi: 10.1111/j.1365-3156.2009.02359.x. Epub 2009 Sep 3. Trop Med Int Health. 2009. PMID: 19732408 Free article. Clinical Trial.
Neuropsychiatric manifestations among HIV-1 infected African patients receiving efavirenz-based cART with or without tuberculosis treatment containing rifampicin.
Mugusi S, Ngaimisi E, Janabi M, Mugusi F, Minzi O, Aris E, Bakari M, Bertilsson L, Burhenne J, Sandstrom E, Aklillu E. Mugusi S, et al. Among authors: janabi m. Eur J Clin Pharmacol. 2018 Nov;74(11):1405-1415. doi: 10.1007/s00228-018-2499-0. Epub 2018 Jul 12. Eur J Clin Pharmacol. 2018. PMID: 30003275 Free PMC article.
Pharmacokinetic and pharmacogenomic modelling of the CYP3A activity marker 4β-hydroxycholesterol during efavirenz treatment and efavirenz/rifampicin co-treatment.
Ngaimisi E, Minzi O, Mugusi S, Sasi P, Riedel KD, Suda A, Ueda N, Bakari M, Janabi M, Mugusi F, Bertilsson L, Burhenne J, Aklillu E, Diczfalusy U. Ngaimisi E, et al. Among authors: janabi m. J Antimicrob Chemother. 2014 Dec;69(12):3311-9. doi: 10.1093/jac/dku286. Epub 2014 Aug 4. J Antimicrob Chemother. 2014. PMID: 25096076
Heart failure in Tanzania and Sweden: Comparative characterization and prognosis in the Tanzania Heart Failure (TaHeF) study and the Swedish Heart Failure Registry (SwedeHF).
Makubi A, Hage C, Sartipy U, Lwakatare J, Janabi M, Kisenge P, Dahlström U, Rydén L, Makani J, Lund LH. Makubi A, et al. Among authors: janabi m. Int J Cardiol. 2016 Oct 1;220:750-8. doi: 10.1016/j.ijcard.2016.06.239. Epub 2016 Jun 29. Int J Cardiol. 2016. PMID: 27393861 Free PMC article.
Long-term efavirenz autoinduction and its effect on plasma exposure in HIV patients.
Ngaimisi E, Mugusi S, Minzi OM, Sasi P, Riedel KD, Suda A, Ueda N, Janabi M, Mugusi F, Haefeli WE, Burhenne J, Aklillu E. Ngaimisi E, et al. Among authors: janabi m. Clin Pharmacol Ther. 2010 Nov;88(5):676-84. doi: 10.1038/clpt.2010.172. Epub 2010 Sep 29. Clin Pharmacol Ther. 2010. PMID: 20881953 Clinical Trial.
CCL3L1 copy number, HIV load, and immune reconstitution in sub-Saharan Africans.
Aklillu E, Odenthal-Hesse L, Bowdrey J, Habtewold A, Ngaimisi E, Yimer G, Amogne W, Mugusi S, Minzi O, Makonnen E, Janabi M, Mugusi F, Aderaye G, Hardwick R, Fu B, Viskaduraki M, Yang F, Hollox EJ. Aklillu E, et al. Among authors: janabi m. BMC Infect Dis. 2013 Nov 12;13:536. doi: 10.1186/1471-2334-13-536. BMC Infect Dis. 2013. PMID: 24219137 Free PMC article.
Effect of rifampicin and CYP2B6 genotype on long-term efavirenz autoinduction and plasma exposure in HIV patients with or without tuberculosis.
Ngaimisi E, Mugusi S, Minzi O, Sasi P, Riedel KD, Suda A, Ueda N, Janabi M, Mugusi F, Haefeli WE, Bertilsson L, Burhenne J, Aklillu E. Ngaimisi E, et al. Among authors: janabi m. Clin Pharmacol Ther. 2011 Sep;90(3):406-13. doi: 10.1038/clpt.2011.129. Epub 2011 Aug 3. Clin Pharmacol Ther. 2011. PMID: 21814190 Clinical Trial.
β-defensin genomic copy number is associated with HIV load and immune reconstitution in sub-saharan Africans.
Hardwick RJ, Amogne W, Mugusi S, Yimer G, Ngaimisi E, Habtewold A, Minzi O, Makonnen E, Janabi M, Machado LR, Viskaduraki M, Mugusi F, Aderaye G, Lindquist L, Hollox EJ, Aklillu E. Hardwick RJ, et al. Among authors: janabi m. J Infect Dis. 2012 Oct 1;206(7):1012-9. doi: 10.1093/infdis/jis448. Epub 2012 Jul 26. J Infect Dis. 2012. PMID: 22837491
177 results